Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × Denosumab × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Neoplasms 8 Prostatic Neoplasms 6 Multiple Myeloma 5 Fractures, Bone 4 Neoplasm Metastasis 3 Bone Diseases, Metabolic 3 Spinal Cord Compression 2 Parathyroid Neoplasms 2 Osteoporosis 2 Lymphoma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Smoldering Multiple Myeloma 1 Paraproteinemias 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplastic Processes 1 Neoplastic Cells, Circulating 1 Neoplasms, Plasma Cell 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hyperparathyroidism, Primary 1 Hypercalcemia 1 Humoral Hypercalcemia Of Malignancy 1 Hormone Refractory Prostate Cancer 1 Hodgkin Disease 1

Interventions

Gemcitabine 42 Cisplatin 29 pembrolizumab 25 Paclitaxel 12 Docetaxel 12 atezolizumab 11 Nivolumab 10 Mitomycin 10 avelumab 9 Carboplatin 9 Cystectomy 8 durvalumab 7 Sunitinib 7 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 apaziquone 5 Vinblastine 5 Platinum 5 Methotrexate 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4 vinflunine 3 tisotumab vedotin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡